Kyowa Hakko USA, Inc. - About Us

 Pharmaceutical Products & Services

Kyowa Hakko USA, Inc. – The Company

Kyowa Hakko Kogyo Co., Ltd., a research-oriented company with special strengths in biotechnology, is dedicated to the creation of new value in the life sciences, centered on pharmaceuticals. In this way, the Company employs 7,700 people worldwide and strives to contribute to the health and well being of people around the world.

On its establishment in 1949, Kyowa Hakko engaged in the mass production of streptomycin, contributing to the eradication of tuberculosis in Japan. The Company has since developed numerous drugs, including anticancer agent Mytomycin C, which is now sold worldwide as a leading chemotherapy agent. In addition to anticancer agents, Kyowa Hakko is actively engaged in the R&D, production, and sale of pharmaceuticals that address a wide variety of other medical needs, including agents to treat hypertension, allergies, and neurological disorders. Kyowa Hakko’s Pharmaceuticals operations are now the Company’s core business field.

The Company has also worked to apply its advanced biotechnology capabilities to mass-produce various types of amino and nucleic acids, including glutamic acid and lysine. Kyowa Hakko applies these capabilities to other areas as well, with a focus on its Food and Bio-Chemicals operations.

At the Bio-Chemical Company operations, Quality Assurance is paramount to long-term success. Kyowa Hakko Bio-Chemicals Company aims to provide products and services with quality superior to those from other companies and also earn the satisfaction and trust of our customers. This is a company wide goal from R&D to production to sales.

To further enhance quality assurance in products and services, we will continue to improve Kyowa’s international standard QA systems with full GMP, ISO 9002, and HACCP compliance at all plants and facilities. Of the five Bio-Chemical production facilities in Hofu, Ube, and Sakai (Japan); Shanghai (China); and Cape Girardeau (US), Hofu, Ube, and Sakai are inspected the US FDA and European authorities.

Research & Development at Kyowa Hakko employs about 1,400 staff most of which are located at our four main research laboratories located in Tokyo, Hofu, Sakai and Tsukuba, Japan.

Sub Menu  

Products/Services
Contact Us
Visit Our Website

Address

	Kyowa Hakko USA, Inc.
	767 Third Avenue 19th Floor New York, NY 10017 USA
Tel.	+1 212 319 5353
Fax	+1 212 421 1283